It has been hypothesized that antibodies against recoverin, a protein involved in cancer-associated retinopathy (CAR) [44], or gephyrin [31], a protein localized in rat retina [45], could have a role in patients with mixed SPS and retinopathy phenotypes. The gene discussed is RCVRN; the disease is cancer-associated retinopathy.